Interview with Guy Wouters, founder and CEO of Fat-Stem
Fat-Stem is the first company in Europe to use adipose-derived mesenchymal stem cells for therapeutic use in animals. We spoke with Guy Wouters, founder and CEO of Fat-Stem, about how it all started, how the company grew and how the company operates today. He gives us insight into the regulatory framework for cell therapies in […]
Digitize Your ATMP Production Process: Is It Worth It?
As with other drug molecules, ATMP’s have to comply to the Good Manufacturing Practice (GMP) guidelines, which require the meticulous assessment of both quality and consistency of the end product. This needs a careful monitoring of the entire manufacturing process, which is both a challenge and an opportunity for the ATMP field. Investing in efficient, […]
at.las academy online!
We created the at.las academy. This online ATMP platform is home to all at.las content- such as webinar recordings, testimonials from colleague developers or point of view articles- and to our new e-learning module, where you can learn from expert experiences. The academy is a collaborative project. If you have content to share, get in […]
BIO.BE Webinar on ‘ATMP: Belgian legislation at a glance’
About 2 years ago a milestone was set in the Belgian Advanced Therapy Medicinal Products (“ATMP”) legislation. The publication took place on October 30th 2018, modifying the law of December 19th 2008 regarding the collection and use of human body material for the purpose of human therapeutic applications or scientific research. This law enables progress […]
The Center of Cell therapy and Regenerative Medicine (CCRG) of UZA/UAntwerpen
Within the CCRG, the University of Antwerp and the UZA collaborate on the development of immunotherapies. These are treatments that wake up the immune system and makes the body stronger in its fight against cancer. Since 2005, they started with the administration of the first safe experimental therapy to patients with different types of cancers […]
SCINUS Webinar on ‘Upscaling: Optimize your cell therapy process for production in a bioreactor’
Are you working on a promising cell therapeutic product? Very well! But have you considered adapting your cell therapy process for an upscaled production? Larger dosages are certainly needed when you move into clinical trials and even further towards market authorization. It is key to initiate this optimization step early in your development as changes […]
On-line roundtable on ‘ATMP logistic challenges’
Join us for an interesting roundtable on ‘ATMP logistic challenges’, in collaboration with VIL, Flanders innovation cluster for Logistics, and moderated by Inovigate. When? October 8th, from 11 am till 12.15 pm. Where? This is an on-line roundtable. You will receive the link for participation upon registration. What is it about? The market for cell and […]
Meet Yanick Fanton, Lab Director at Beta-Cell N.V.
The Covid-19 lockdown prevented us to organize a ‘real life’ network meeting to bring our at.las members together. Luckily, it didn’t prevent us to find new ways of getting to know each other. During a zoom-meeting, we had a nice talk with Yanick Fanton, Lab Director at Beta-Cell N.V. In this interview, she introduces Beta-Cell and talks about the […]
TRIUM training on ‘Good Clinical Practice’
Join us for this exciting on-line training on ‘Good Clinical Practices’ or GCP, organized by the at.las member TRIUM. The training will take place on June 30th, from 3 pm till 5 pm. And yes, it is FREE!!! What is the training about? For the novice research professional, the clinical research field can seem both […]